Emergence of drug resistance during an influenza epidemic: insights from a mathematical model

The Journal of Infectious Diseases
N I StilianakisFrederick G Hayden

Abstract

A model was developed for the emergence of drug-resistant influenza viruses during a closed population influenza epidemic that occurs in a single wave. The model was used to consider several treatment and chemoprophylaxis strategies and to determine their effects on the spread of the infection. The model predicts frequent emergence and transmission of drug-resistant viruses with certain treatment scenarios. According to the model, chemoprophylaxis of susceptible persons (without treatment of those who are symptomatic) may be the best way to reduce the force of an epidemic and to keep development of drug resistance low. The model predictions indicate that the relative transmissibility of resistant variants compared with wild type virus and the choice of the treatment or chemoprophylaxis strategy can be decisive for the spread of drug-resistant viruses, a feature that may be crucial in a pandemic.

Citations

Aug 19, 2007·Bulletin of Mathematical Biology·Sze-Bi Hsu, Ying-Hen Hsieh
Aug 19, 2007·Bulletin of Mathematical Biology·Murray E AlexanderJianhong Wu
Jun 8, 2011·Environmental Health and Preventive Medicine·Ayako Sumi, Ken-ichi Kamo
Apr 24, 2013·Journal of Theoretical Biology·Lisa N MurilloAlan S Perelson
Jun 5, 2002·Lancet·Nikolaos I StilianakisFrederick G Hayden
Sep 13, 2001·Trends in Microbiology·M Lipsitch
Jan 1, 2007·Journal of Biological Dynamics·James M Hyman, Jia Li
May 11, 2013·American Journal of Epidemiology·Ian H SpicknallJoseph N S Eisenberg
Dec 20, 2005·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Woo-Joo Kim
Jul 5, 2007·Journal of the Royal Society, Interface·Florence DébarreRoland R Regoes
Feb 19, 2010·Journal of the Royal Society, Interface·Nikolaos I Stilianakis, Yannis Drossinos
Jan 26, 2007·Proceedings. Biological Sciences·Andreas HandelRustom Antia
May 18, 2007·Proceedings. Biological Sciences·Murray E AlexanderPing Yan
Feb 14, 2008·Proceedings. Biological Sciences·Seyed M Moghadas
Oct 1, 2010·Proceedings. Biological Sciences·Elsa Hansen, Troy Day
Jun 12, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D J Austin, R M Anderson
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·F G Hayden
Mar 16, 2004·Annual Review of Public Health·Jim Koopman
Jul 17, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Eunha ShimAlison P Galvani
Jan 22, 2009·BMC Infectious Diseases·Martin EichnerBeatriz Vidondo
Jan 24, 2009·BMC Infectious Diseases·Julien ArinoSeyed M Moghadas
Nov 1, 2008·Virology Journal·Stefan O BrockmannMartin Eichner
Oct 17, 2006·PLoS Computational Biology·Andreas HandelRustom Antia
Jan 27, 2007·PLoS Medicine·Marc LipsitchBruce R Levin
Nov 23, 2010·Journal of Epidemiology·Ayako SumiNobumichi Kobayashi
Oct 29, 2009·Emerging Infectious Diseases·Carline van den DoolJacco Wallinga
Sep 27, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hiroshi SuzukiIsamu Sato
Mar 5, 2013·Journal of Mathematical Biology·Krisztian Magori, Andrew W Park
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·S M BlowerJ Mills
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J AustinR M Anderson
Nov 8, 2014·Evolution, Medicine, and Public Health·Mark M TanakaCarl T Bergstrom
Apr 14, 2009·Journal of Theoretical Biology·Shingo IwamiShinji Nakaoka
Apr 22, 2006·Science·Roland R Regoes, Sebastian Bonhoeffer
Dec 20, 2008·Journal of Theoretical Biology·Shingo IwamiXianning Liu
Jun 22, 2007·Journal of Theoretical Biology·Yaji XuAlan S Perelson
Apr 10, 2007·Mathematical Biosciences·James M McCaw, Jodie McVernon
Mar 4, 2005·Journal of the American Geriatrics Society·Nancy A RisebroughPaul I Oh
Mar 1, 2007·Influenza and Other Respiratory Viruses·J McVernonJ D Mathews

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.